Skip to main content

Table 1 Clinical characteristics of patients with migraine

From: Interictal osmophobia is associated with longer migraine disease duration

  n (%)
Patients with Migraine: 113 (100)
 female 99 (87.6)
 male 14 (12.4)
Migraine: 113 (100)
 Migraine with Aura 50 (44.2)
 Migraine without Aura 63 (55.8)
 Episodic Migraine 95 (84.1)
 Chronic Migraine 18 (15.9)
Concomitant Tension type headache:
 Sporadic 15 (13.3)
 Episodic 8 (7.1)
 Chronic 2 (1.8)
Concomitant disease:
 Internal disease 45 (39.8)
 Orthopaedic disorders 22 (19.5)
 Cancer 3 (2.7)
Concomitant Mental disorder:
 Anxiety disorder 3 (2.7)
 Depression 20 (17.7)
Concomitant pain disorders:
 Chronic Cervical pain 25 (22.1)
 Chronic Thoracic pain 3 (2.7)
 Chronic lower back pain 22 (19.5)
Analgesics used in migraine attacks:
 Ibuprofen 42 (37.2)
 Acetylsalicylic acid 13 (11.5)
 Triptans 69 (61.1)
 Dipyrone 10 (8.8)
 Paracetamol/Acetaminophen 14 (12.4)
 Dimenhydrinat 1 (0.9)
Migraine prophylactic medication:
 Beta-blockers 17 (15.0)
 Topiramate 5 (4.4)
 Flunarizine 3 (2.7)
 Amitryptiline 5 (4.4)
 Onabotulinumtoxin A 1 (0.9)
 monoclonal antibodies against CGRP/CGRP-receptor 2 (1.8)
 Age in years 46 ± 14 (range: 18–78)
 Women 47 ± 14 (range: 19–78)
 Men 41 ± 14 (range: 18–66)
 Migraine with aura 44 ± 13 (range: 22–68)
 Migraine without aura 48,11 ± 15 (range: 18–78)
 Episodic migraine 46 ± 14 (range: 18–78)
 Chronic migraine 48 ± 12 (range: 24–66)
 BMI in kg/m2 24.4 ± 4.4 (range: 17.2–43.4)
 Women 24.3 ± 4.6 (range: 17.2–43.4)
 Men 24.5 ± 3.3 (range: 19.8–31.2)
 Migraine with aura 25.5 ± 4.8 (range: 18.1–43.4)
 Migraine without aura 23.5 ± 3.9 (range: 17.2–38.4)
 Episodic migraine 24.2 ± 4.4 (range: 17.2–43.4)
 Chronic migraine 24.9 ± 4.5 (range: 18.8–33.5)
  1. Age and BMI described as Mean ± standard deviation (SD)